Deciphering the molecular mechanisms of parasite-host interactions. The completion of genome projects for several helminths of veterinary significance has provided novel insights into the fundamentals of helminth biology. One outcome is the identification of microRNAs, a subclass of small regulatory RNAs which in plants and mammalian cells control diverse biological processes at the posttranscriptional level. We have discovered the presence of helminth miRNAs within host cells with the ability t ....Deciphering the molecular mechanisms of parasite-host interactions. The completion of genome projects for several helminths of veterinary significance has provided novel insights into the fundamentals of helminth biology. One outcome is the identification of microRNAs, a subclass of small regulatory RNAs which in plants and mammalian cells control diverse biological processes at the posttranscriptional level. We have discovered the presence of helminth miRNAs within host cells with the ability to mimic mammalian miRNAs to modulate innate immune responses. This project will discover how helminths hijack the mammalian miRNA machinery to regulate host gene expression and thus support long-term infection. The outcomes will highlight new avenues for the control of these persistent worm infections.Read moreRead less
Harnessing the genome of the Australian paralysis tick to develop effective control products. This project aims to examine the potent cocktail produced by the salivary gland of Australia's paralysis tick. The paralysis tick continues to cause severe illness and deaths for companion pets with up to 100,000 cases of toxicoses per year. This project aims to develop new safe treatments and/or preventative vaccines.
Troublesome ticks: a new molecular toolkit to investigate zoonotic tick-borne pathogens in Australia. This project will use the latest molecular diagnostic techniques to address unanswered questions about potential tick-transmitted diseases of humans and companion animals in Australia. The study will identify 'hot-spots' for tick-borne pathogens, identify areas of potential risk for humans, and investigate vector-host-pathogen interactions nationwide.
Ecology and transmission of tick-borne disease in Australia. Ecology and transmission of tick-borne disease in Australia. This project aims to determine the bacterial, protozoal and viral biodiversity in wildlife ticks and their native mammal hosts, and provide new information about the biology and transmission dynamics of these microorganisms and their potential to cause disease in wildlife, domesticated animals and humans. Anticipated outcomes are improved diagnostic tests and management proto ....Ecology and transmission of tick-borne disease in Australia. Ecology and transmission of tick-borne disease in Australia. This project aims to determine the bacterial, protozoal and viral biodiversity in wildlife ticks and their native mammal hosts, and provide new information about the biology and transmission dynamics of these microorganisms and their potential to cause disease in wildlife, domesticated animals and humans. Anticipated outcomes are improved diagnostic tests and management protocols for tick-borne disease in Australia.Read moreRead less
Chemo-prevention of tropical canine parasitoses and vector-borne diseases. This project will determine the prevalence and diversity of established, emerging and novel canine vector-borne agents and endoparasites in a tropical setting by using conventional and next generation molecular diagnostic tools. It will fill an important gap by providing independently-verified evidence on how well canine anti-parasitic products marketed in Australia and Asia by Bayer Animal Health, perform in high-infecti ....Chemo-prevention of tropical canine parasitoses and vector-borne diseases. This project will determine the prevalence and diversity of established, emerging and novel canine vector-borne agents and endoparasites in a tropical setting by using conventional and next generation molecular diagnostic tools. It will fill an important gap by providing independently-verified evidence on how well canine anti-parasitic products marketed in Australia and Asia by Bayer Animal Health, perform in high-infection pressure settings, as a chemo-preventative for these disease agents. Tropical regions spanning northern Australia and Southern Asia are highly conducive to a plethora of canine vector-borne and parasitic pathogens that cause significant morbidity and mortality in dogs. Many of these agents also pose a risk to public health. The outcomes will be directly translated to best-practice guidelines for the advancement of companion animal (and indirectly human) health and welfare.Read moreRead less